Hospital Universitario de Guadalajara, Spain Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2010
NCT01622777
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Alejandra Guillermina Miranda Diaz | Hospital de Guadalajara | Hospital General Universitario de Guadalajara | Hospital Universitario de Guadalajara. Spain